World Health Organization (WHO) Guidelines Development Group (GDG):
Dr. Hala-AL-Nawaiseh have been selected as a member of the World Health Organization (WHO) Guidelines Development Group (GDG) for the rapid advice on the use of GLP-1 Receptor Agonists. This appointment reflects a valuable opportunity to contribute to global health policy and evidence-based recommendations in the field of metabolic and chronic disease management.
Scientific e-book" Diabetes and Pregnancy: A Journey Through the Past, Present, and Future":
Prof Eman Badran, Consultant Neonatologist at the University of Jordan Hospital, contributed to the authorship and writing of the scientific e-book titled:" Diabetes and Pregnancy: A Journey Through the Past, Present, and Future", upon invitation from the Bahrain Diabetes Society, in conjunction with the Women and Child Health Conference held in the Kingdom of Bahrain. The book launch ceremony was held under the patronage of Dr. Sheikh Mohammed bin Abdullah Al Khalifa, Chairman of the Supreme Council of Health in Bahrain
Venus International Women Awards (VIWA)-2025:
Dr. Hala-AL-Nawaiseh has received the Venus International Women Awards (VIWA)-2025 by the Venus International Foundation (VIF) -Young Woman Researcher in the field of Nutrition.To recognize 'Best Woman Researchers' who are demonstrated creativity and excellence in their discipline.
Comittee Membership"Special formula and infant feeding commitee at Jordan Food and Drug Administration.
Dr.Hala Khaled Nawaiseh has been selected as a member of Special formula and infant feeding commitee at Jordan Food and Drug Administration. The comittee is responsible for developing, evaluating, and ensuring the safety, quality, and regulation of special formulas and infant feeding products to protect public health and promote optimal infant nutrition.
AUB Board Designated Professorship Award:
Prof. Lara Nasreddine -American University of Beirut received AUB Board Designated Professorship Award- In recognition of accomplishments, forward-looking leadership, and trajectory for further advancement and broader impact.